Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain
NCT ID: NCT02875496
Last Updated: 2019-11-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2016-08-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
NCT03699514
Additional Post Hoc Analysis and Clinical Data Collection
NCT02860416
Brain Network Activation Analysis in Epilepsy
NCT03265925
Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials
NCT02418208
Normative Data of Brain Network Activation
NCT01742858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The need of objective measures that will help the clinician in its decision-making in brain-related pathologies is recognized. BNA is a new imaging modality that has been developed to fill this gap.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy aging
Subjects meeting criteria for healthy aging No intervention administered
No interventions assigned to this group
Early Alzheimer Disease
Subjects meeting criteria for Early Alzheimer Disease No intervention administered
No interventions assigned to this group
Depression
Subjects meeting criteria for Depression No intervention administered
No interventions assigned to this group
MCI-Mild Cognitive Impairment
Subjects meeting criteria for MCI-Mild Cognitive Impairment No intervention administered
No interventions assigned to this group
General Arm
Subjects not meeting criteria for any of the other arms (Healthy, Early Alzheimer's, Depression, or MCI)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 50-years and above.
* Able to speak, read and understand English
* Willingness to participate and able to give informed consent.
* If corrected vision: only Glasses should be used during the study testing
* BDI score \<14
* Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR,
* MMSE score ≥25
* BDI score \<14
* Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR, as determined by clinical evaluation by a research clinician and the Mini International Neuropsychiatric Interview (MINI).
* MMSE score \<24
* MoCA\<20
* Presence of an early and significant episodic memory impairment
* BDI score \>14
* Subjects meeting full diagnostic criteria for MDD without psychotic features per the DSM IV-TR
* HAM-D 17-item: Total score of 16 or higher at visit 1.
* BDI score \<14
* Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR
* MMSE scores according to Number of years of Education:
MMSE score Years of Education 17-18 ≤6 20-21 7-8 23-24 ≥10
-20\<MoCA score \>26
Exclusion Criteria
* Any CNS neurologic disorder
* Significant sensory deficits.
* Use of a hearing aid that occupies the ear canal
* Any neuropsychological disorders
* History of special education
* Substance abuse in the last 3 months
* History of any clinically significant brain trauma as determined by the investigator.
* Clinically diagnosed with a concussion in the past year.
For Arm 1 Healthy
* Any chronic disease or condition which affects the nervous system as determined by clinical neurological evaluation, medical history or PI discretion.
* Any psychiatric disorder,
* History of any medication affecting CNS within the last 3 months
For Arm 2 Early Alzheimer's Disease
* Any chronic disease or condition other than current pathology
* Any other psychiatric disorder
* CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.
For Arm 3 Depression
* Any chronic disease or condition other than current pathology
* Any psychiatric disorder other than Depression
* CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.
For Arm 4 Mild Cognitive Impairment
* Any chronic disease or condition other than current pathology
* Any other psychiatric disorder
* CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.
50 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ElMindA Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey Lowenkron, MD
Role: PRINCIPAL_INVESTIGATOR
Chief Medical Officer, The Villages Health
Carla VandeWeerd, PhD
Role: PRINCIPAL_INVESTIGATOR
Director of Research, The Villages Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Villages Health
The Villages, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ELM-26
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.